{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-023442","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.662509+00:00","generated_at":"2026-05-22T04:10:30.414571+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Avalo posts updated investor presentation; no material new facts disclosed","bullets":["Company posted an updated investor presentation on its website on May 8, 2025.","Presentation is intended for use in investor meetings; no specific financial or pipeline updates provided in the filing.","No earnings, clinical data, or guidance changes included in the 8-K or exhibit excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-023442","json":"https://secwatch.observer/filing/0001628280-25-023442.json","markdown":"https://secwatch.observer/filing/0001628280-25-023442.md","text":"https://secwatch.observer/filing/0001628280-25-023442.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828025023442/0001628280-25-023442-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828025023442/avtx-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T04:10:30.414571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}